Evidence map›Paper›PMID 33430068›Full record

ArticleMolecules (Basel, Switzerland)2021

The Impact of Olive Oil Compounds on the Metabolic Reprogramming of Cutaneous Melanoma Cell Models.

Cheila Brito, Ana Tomás, Sandra Silva, Maria Rosário Bronze, Ana Teresa Serra, Marta Pojo

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Cheila BritoUnidade de Investigação em Patobiologia Molecular (UIPM) do Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., 1099-023 Lisboa, Portugal.
Ana TomásUnidade de Investigação em Patobiologia Molecular (UIPM) do Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., 1099-023 Lisboa, Portugal.
Sandra SilvaiBET, Instituto de Biologia Experimental e Tecnológica, 2780-157 Oeiras, Portugal.
Maria Rosário BronzeiBET, Instituto de Biologia Experimental e Tecnológica, 2780-157 Oeiras, Portugal.ORCID 0000-0001-5016-4634
Ana Teresa SerraiBET, Instituto de Biologia Experimental e Tecnológica, 2780-157 Oeiras, Portugal.
Marta PojoUnidade de Investigação em Patobiologia Molecular (UIPM) do Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., 1099-023 Lisboa, Portugal.ORCID 0000-0002-4036-6731
Instituto de Biologia Experimental e Tecnológica · PTUniversity of Lisbon · PT

Funding

iNOVA4Health - UIDB/04462/2020, a program financially supported by Fundação para a Ciência e Tecnologia/Ministério da Educação e Ciência UIDB/04462/2020
6 · The paper itself

Abstract

Cutaneous melanoma is the deadliest type of skin cancer, characterized by a high molecular and metabolic heterogeneity which contributes to therapy resistance. Despite advances in treatment, more efficient therapies are needed. Olive oil compounds have been described as having anti-cancer properties. Here, we clarified the cytotoxic potential of oleic acid, homovanillyl alcohol, and hydroxytyrosol on melanoma cells. Metabolic viability was determined 48 h post treatment of A375 and MNT1 cells. Metabolic gene expression was assessed by qRT-PCR and Mitogen-Activated Protein Kinase (MAPK) activation by Western blot. Hydroxytyrosol treatment (100 and 200 µM) significantly reduced A375 cell viability (

Indexed as

Antineoplastic Agents, PhytogenicMelanomaSkin NeoplasmsCell Line, TumorCell SurvivalCellular Reprogramming TechniquesHumansMAP Kinase Signaling SystemNeoplasm ProteinsOlive OilPhenylethyl Alcohol3,4-dihydroxyphenylethanolAntineoplastic Agents, PhytogenicNeoplasm ProteinsOlive OilPhenylethyl Alcoholcell metabolismcutaneous melanomahomovanillyl alcoholhydroxytyrosolmolecular mechanismsoleic acid

Identifiers

PMID33430068
PMCPMC7827395
OpenAlexW3119640327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.